SciBase collaborates with Johnson & Johnson Consumer Inc to develop AI-based screening tool for detection of atopic dermatitis in infants.

NORDIC BUSINESS REPORT-November 8, 2022-SciBase collaborates with Johnson & Johnson Consumer Inc to develop AI-based screening tool for detection of atopic dermatitis in infants

(C)2022 M2 COMMUNICATIONS http://www.m2.com

Medical technology company SciBase Holding AB (STO: SCIB), a developer of augmented intelligence-based solutions for skin disorders, disclosed on Tuesday that it has signed a collaboration agreement with healthcare company Johnson & Johnson Consumer Inc to develop a unique AI-based screening tool that will predict the development of atopic dermatitis, a common type of eczema in infants.

SciBase said that this AI-based solution may be able to predict the risk of an infant developing atopic dermatitis. The method will be based on SciBase's Electrical...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT